Holen Sie sich die Stockscreener-App
472.21
3.52%
-17.21
Vorhandelsmarkt:
472.00
-0.21
-0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
Why United Therapeutics (UTHR) Shares Are Falling Today - finance.yahoo.com
A Look at United Therapeutics Corp (UTHR) After 3.5% Decline -- GF Value $427.97 vs Price $472.21 - GuruFocus
United Therapeutics CEO Rothblatt sells $4.67m in stock after option exercise - Investing.com
Form 4 United Therapeutics Corporation For: 24 September - Investing.com India
After exercising 9,500 options, family trusts sold United Therapeutics (UTHR) shares under a pre-arranged plan. - Stock Titan
United Therapeutics Falls as Goldman Sachs Sets $321 Price Target - citybiz
United Therapeutics Corporation (UTHR) stock price, news, quote and history - Yahoo Finance UK
United Therapeutics, Sagimet drop as Goldman issues Sell (UTHR) - Seeking Alpha
United Therapeutics (NASDAQ:UTHR): A Growth-at-a-Reasonable-Price Candidate - ChartMill
Goldman Sachs initiates United Therapeutics stock with sell rating - Investing.com
Under a pre-arranged plan, United Therapeutics (UTHR) CEO’s family trusts exercise 9,500 options and sell the shares. - Stock Titan
United Therapeutics: Strong Catalyst Flow Bodes Well For Near-Term Growth (NASDAQ:UTHR) - Seeking Alpha
United Therapeutics Corporation at Bernstein Healthcare Forum Transcript - GuruFocus
United Therapeutics CEO Rothblatt sells $4.7m in stock By Investing.com - Investing.com Australia
United Therapeutics CEO Rothblatt sells $4.7m in stock - Investing.com
United Therapeutics (UTHR) CEO sells shares at nearly $500 each - Stock Titan
United Therapeutics CEO Rothblatt sells $4.7m in UTHR shares By Investing.com - Investing.com Nigeria
Form 4 United Therapeutics Corporation For: 22 September By Investing.com - Investing.com Canada
United Therapeutics CEO Rothblatt sells $4.7m in UTHR shares - Investing.com
CEO stock sale near $500 a share was preplanned, United Therapeutics (UTHR) says - Stock Titan
United Therapeutics (NASDAQ:UTHR) Screens as a High-Quality, Debt-Free Stock - ChartMill
United Therapeutics EVP Paul A. Mahon Executes Stock Options and Sells Shares Under 10b5-1 Plan - kalkinemedia.com
United Therapeutics (UTHR) CEO sells 9,500 shares under preset plan - Stock Titan
United Therapeutics (NASDAQ: UTHR) general counsel sells shares near $500 - Stock Titan
United Therapeutics (NASDAQ: UTHR) CEO exercises 9,500 options and sells matching shares - Stock Titan
United Therapeutics (NASDAQ: UTHR) CEO exercises options and sells stock under preset plan - Stock Titan
Director Nilda Mesa Sells 228 Shares of United Therapeutics Corp (UTHR) - GuruFocus
United Therapeutics (NASDAQ: UTHR) CEO exercises 9,500 options, then sells the shares under preset plan - Stock Titan
United Therapeutics (UTHR) director exercises options, then sells shares - Stock Titan
United Therapeutics CEO Martine Rothblatt sells $4.7m in shares By Investing.com - Investing.com Nigeria
United Therapeutics Corporation at Morgan Stanley Global Healthcare Conference Transcript - GuruFocus
United Therapeutics CEO Martine Rothblatt sells $4.7m in shares - Investing.com
United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares - Stock Titan
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now? - Zacks Investment Research
United Therapeutics (UTHR) Sets $477.6 Million Buyback. Can Pipeline Funding Keep Pace? - Yahoo Finance
Rothblatt Executes Stock Option Exercise and Multiple Share Sales Under 10b5-1 Plan at United Therapeutics - kalkinemedia.com
United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan
United Therapeutics CEO Martine Rothblatt sells $4.7m in stock By Investing.com - Investing.com Australia
United Therapeutics at Cantor healthcare conference: fibrosis push widens By Investing.com - Investing.com Australia
United Therapeutics CEO Martine Rothblatt sells $4.7m in stock - investing.com
United Therapeutics (UTHR) CEO exercises options and sells 9,500 shares in preset plan - Stock Titan
United Therapeutics Launches $477.6M Accelerated Share Buyback - Minichart
United Therapeutics Launches $477.6 Million Accelerated Share Repurchase With Citi - TradingView
United Therapeutics (UTHR) moves to return $4B to shareholders with new buyback - Stock Titan
United Therapeutics (UTHR) CEO sells 9,500 shares under preset trading plan - Stock Titan
United Therapeutics Corporation at Wells Fargo Healthcare Conference Transcript - GuruFocus
United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization - marketscreener.com
United Therapeutics Corporation (UTHR) Stock Analysis: Insights on a 36.24% Potential Upside - DirectorsTalk Interviews
United Therapeutics (NASDAQ: UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
United Therapeutics (UTHR) Down 8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Anheuser-Busch plant in Merrimack sold to United Therapeutics for $47.5M - UnionLeader.com
United Therapeutics EVP Paul A. Mahon Executes Stock Option Exercise and Sells Shares Under 10b5-1 Plan - kalkinemedia.com
United Therapeutics (UTHR) counsel sells 8,300 shares under preset plan - Stock Titan
United Therapeutics (UTHR) CEO offloads 9,500 shares in planned trade - Stock Titan
United Therapeutics (NASDAQ:UTHR) Offers Growth At A Fair Price - Kalkine Media
1.75%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):